UBS Ups BrightSpring Target to $42, Reiterated Buy After Beat-and-Raise Q3

BrightSpring Health Services, Inc. (NASDAQ:BTSG) is one of the best digital health stocks to buy now. On October 29, one day after the company's release of Q3 results, UBS analyst A.J. Rice. reiterated Buy and lifted their 12-month price target to $42 (from $35), citing a classic “beat-and-raise” quarter and management’s confidence, especially around specialty/infusion momentum carrying into 2026. On October 28, BrightSpring Health Services, Inc. (NASDAQ:BTSG) reported revenue of $3.334 billion (+28.2% Y ...